Patent · US Active

Kinase inhibitors

US8119655B2 · kind B2 · utility

53Cited by
62References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2006
Grant dateFeb 21, 2012
Priority date—
Expiry dateFeb 25, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds, pharmaceutical compositions, kits and methods are provided for use with kinases that comprise a compound selected from the group consisting of:wherein the variables are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.